PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Kemin Industries, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kemin Introduces First-ever Palatant with Antioxidant Protection for Low-fat Petfood Diets in North America - To conquer the unique palatability and stability challenges associated with low-fat petfood diets, Kemin launches PALFRESH™, a patent-pending portfolio of palatability enhancers with additional antioxidant protection - Kemin.com
Kemin Introduces First-ever Palatant with Antioxidant Protection for Low-fat Petfood Diets in North America

 

NewswireToday - /newswire/ - Des Moines, IA, United States, 2013/04/16 - To conquer the unique palatability and stability challenges associated with low-fat petfood diets, Kemin launches PALFRESH™, a patent-pending portfolio of palatability enhancers with additional antioxidant protection - Kemin.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Low-fat petfood diets have a unique stability challenge because they include less topical fat, which is where antioxidants are typically added to stabilize the kibble. With less topical fat, kibbles from low-fat diets are unevenly coated leaving kibbles susceptible to rapid oxidation. In addition, low-fat diets may have reduced pet acceptance, which can be further compromised by stability challenges.

“Low-fat petfood diets have historically been the most difficult diets to stabilize,” says Lynn Deffenbaugh, global product manager for palatants at Kemin. “The one-size-fits-all antioxidant dosage in topical fats works for standard diets, but low-fat diets are under-dosed because the stability program depends on the antioxidant to be carried by the topical fat.”

PALFRESH is a breakthrough line of palatability enhancers that deliver targeted antioxidant dosage through liquid application, ensuring that petfood kibble is evenly coated and protected from oxidation. PALFRESH also improves shelf-life by utilizing palatants that do not have a pro-oxidant effect an effect that rapidly sacrifices antioxidants and contributes to stability issues.

In addition to stabilizing low-fat diets, PALFRESH maintains better palatability through shelf-life. Trials have shown that while initial palatability between a PALFRESH treated diet and a control diet are similar; diets treated with PALFRESH can preserve palatability better over time.

“We recognized an industry challenge, coupled with the growing consumer demand for weight management diets,” says Giuseppe Abrate, president of the nutrisurance division of Kemin. “So we put our scientists to work using their knowledge and expertise in both ingredient stability and palatability to provide a solution that would meet our customers’ needs.”

Deffenbaugh will share additional research on PALFRESH at Petfood Forum in Schaumburg, Illinois during her presentation entitled,“Stabilization Technology to Deliver and Maintain Palatability throughout Pet Food Shelf Life”, which will take place on Wednesday, April 17 at 10:30 am. In addition to Deffenbaugh’s presentation, Kemin representatives will be available at booth 223.

About Kemin Inspired Molecular Solutions™

Kemin (kemin.com) provides “inspired molecular solutions” specifically developed to provide nutrition and health benefits for humans and animals. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where approximately 500 specialty ingredients are made for the global feed and food industries as well as the health, nutrition and beauty markets. A privately held, family-owned and operated company, Kemin has more than 1,600 employees and operates in 90 countries with manufacturing facilities in Belgium, Brazil, China, India, Italy, Singapore, South Africa and the United states.

Certain statements may not be applicable in all geographical regions. Product labeling and associated claims may differ based upon government requirements.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kemin Industries, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kemin Introduces First-ever Palatant with Antioxidant Protection for Low-fat Petfood Diets in North America

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Erin Hockman / Tina Kendall - Kemin.com 
515-559-5349 / 515-559-5562 erin.hockman[.]kemin.com / tina.kendall[.]kemin.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kemin Industries, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kemin Industries, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  SKS Media | SKS Associates Ltd

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)